glp-1 receptor agonists cardiovascular benefits The effects of beyond obesity and type 2 diabetes: An anti-atherosclerotic action Bridging the gap between GLP1-receptor

The exact date of when retatrutide will be available by prescription is not yet known

GLP-1 agonists also reduced headache risk, with the most significant effect at 3 months (RR: 0.69), remaining statistically significant at 6, 12, and 24 months

Niche-independent high-purity cultures of Lgr5+ intestinal stem cells and their progeny

Trump to bring down the price of its semaglutide-based drugs

Sustainable value chains and pricing insights are becoming key factors as payers focus on cost-effectiveness

Dapagliflozin restores diabetes-associated decline in vasculogenic capacity of endothelial progenitor cells via activating AMPK-mediated inhibition of inflammation and oxidative stress